List of Biotech Companies from USA
Biotech Companies USA : List of Biotech Companies from USA :
- Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group
- Steritas Announces Collaboration with argenx to Advance Evidence for Novel Steroid-sparing Therapeutics
- Cancer Targeted Technology Receives Fast Track $2.4M Grant to Develop an Innovative PSMA-Targeted Small Molecule Drug Conjugate for Prostate Cancer
- Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
- Epirium Bio Presented Late-Breaking Preclinical Data of MF-300 (15-PGDH Enzyme Inhibitor) at the Gerontological Society of America Annual Scientific Meeting 2024
- Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
- Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
- Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium
- Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur
- Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
- MiLaboratories Secures Series A, Raising Total Funding to $10 Million to Revolutionize the World of Genomic Research
- Bayer announces positive topline results for NUBEQA® (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC)
- Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
- Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
- GSK and CureVac to Restructure Collaboration into New Licensing Agreement
- Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases
- Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
- Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
- Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
- RS Oncology Announces Positive Data from a Phase 1 Clinical Trial of RSO-021, a First-in-Class Therapeutic for Malignant Pleural Mesothelioma
- Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
- iCell Gene Therapeutics Announces Positive Clinical Data from Investigator Initiated Phase 1 Trial Evaluating BCMA-CD19 Compound CAR in Patients with Systemic Lupus Erythematosus/Lupus Nephritis Published in Annals of the Rheumatic Diseases
- Sinaptica Therapeutics Selected for StartUp Health’s Alzheimer’s Moonshot
- Cimeio Therapeutics : CD45 ADC and Shielded HSCs Represent a Potentially Universal Therapy for Blood Cancers
- AmorChem’s RNA Zipcode Delivery Technology Investment Exits via New York-Based Kodikaz Therapeutic Solutions, Inc.
- Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases
- Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
- Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design
- Chapter Raises $50 Million Led By XYZ Venture Capital to Help Millions More Seniors Maximize Their Medicare
- NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
- 4M Therapeutics : Novel Preclinical Data Demonstrating Potent Effects of Inhibitors of GSK3β for the Treatment of Bipolar Disorder
- Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
- Be Biopharma Announces New Preclinical Data for Novel B Cell Medicine for the Potential Treatment of Hypophosphatasia
- Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
- Seragon Biosciences completes Pre-Clinical Studies of its novel anti-aging candidate SRN-901
- Cagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive Officer
- FDA Approves ColoSense™ – Geneoscopy’s Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
- OverT Bio Raises $16 Million, Tapping Innovative Reprogramming of Immune Cells to Deliver Next-Generation Therapies
- Inmagene Reports Positive Interim Results from Phase 2a Trial of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-life, for the Treatment of Atopic Dermatitis
- Epredia and NovaScan Announce Intent to Enter U.S. Distribution Agreement for MarginScan™ Device for Non-Melanoma Skin Cancer Detection
- Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
- Nvelop Therapeutics Announces Members of Its Scientific Advisory Board
- Remepy Launches with $15 Million in Funding To Bring First Hybrid Drug To Market
- Qlaris Bio Completes $24 Million Series B Financing Round to Advance QLS‑111, a First-in-class IOP-lowering Drug Candidate for Glaucoma
- BosterBio : 30 years designing high affinity antibodies and immunoassays
- Xeno Biosciences Announces New CEO and Financing
- Jacques Banchereau, PhD Appointed as Chief Scientific Officer at Javelin Biotech
- Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
- Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
- KYinno – Boost your drug discovery with innovative products and services
- S2 Genomics Announces Groundbreaking Single Cell FFPE Sample Prep Isolation Product
- Merck’s Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment
- Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024
- Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
- Seismic Therapeutic – Preclinical Data for Novel Immunoglobulin Sculpting Enzyme
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
- FogPharma Announces $145 Million Financing to Support Ongoing Clinical Development of FOG-001 and Accelerate Helicon Peptide Portfolio
- Animal Biosciences Announces New Canine Clinical Research Evaluating Reversal of Age-Related Signs in Dogs
- Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy
- Promising Results: TGR-63 Enhances Memory in Alzheimer’s Mouse Model
- Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease
- Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
- Rallybio Announces Clinical Proof-of-Concept Results for RLYB211, an Anti-HPA-1a Polyclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), Published in the Journal of Thrombosis and Haemostasis
- Morphogenesis Inc. Acquires TυHURA Biopharma’s First-in-Class Antibody Drug Conjugates (ADCs) Technology Designed to Overcome Acquired Resistance to Cancer Immunotherapy
- Tvardi Therapeutics Announces First Patients Dosed in Phase 2 Trial of TTI-101 in Metastatic Breast Cancer
- U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer
- ARMGO Pharma – developing small molecule Ryanodine Receptor modulators for treating cardiac, musculoskeletal and neurological disorders
- Accegen Biotech – complete cell & molecular biology products and services
- Cytoo – next generation HCS with physiologically relevant cellular models
- BATAVIA BIOSCIENCES – Accelerate Biotechnology
- AgileBio – collaborative tools that enhance research productivity
- Hera BioLabs – implementation of Precision Toxicology
- Samplify Bio – DNA Collection Made Simple
- Biomere – preclinical CRO
- Sekisui XenoTech Provides Pooled Human Liver Homogenate for Evaluation of Drug Metabolizing Enzymes and Proteins
- Creative Bioarray – Cells and Tissue Arrays
- Aduro Biotech – engineered Immunotherapy for Cancer
- Anton Paar – process measuring systems
- Worthington Biochemical – high quality enzymes
- Bavarian Nordic – poxviral-based vaccine
- Lucigen – simplifying genomics
- Biocision – ice-free cooling systems
- Fluidigm – single-cell analysis
- Maverix Biomics – manage next generation sequencing data
- IntelliCyt – cell and bead-based screening solutions
- Biodesix – cancer diagnostics
- LabWorm – social network for scientists
- Mint Labs – neuroimaging in the cloud
- Genome Profiling – epigenetic biomarkers
- BOC Sciences – inhibitors and custom synthesis
- Starna – spectrophotometer, fluorimeter and colourimeter cells
- Alkahest – developing therapies derived from blood
- Swift Biosciences – genomics and personalized medicine
- BioFunds.org – you can finance research for Free !
- CD Genomics – Whole Genome Sequencing
- Imabiotech – evaluation of drug efficacy and toxicity
- Bioagilytix – bioanalytical CRO for your large-molecule needs
- Exosome Diagnostics – biofluid-based diagnostics
- Crownbio – cancer Immunotherapy and xenograft models
- InSphero – organotypic 3D cell culture models
- Labcyte – revolutionizing Liquid Handling
- Gel Company – gel documentation systems
- Promab – custom rabbit monoclonal antibody
- SkylineDx – innovative signature-based diagnostic tests
- Mobio – RNA purification and isolation method
- InDevR – accelerate vaccine characterization and production
- Bioo Scientific – increasing sensitivity, flexibility and speed of NGS
- Creative Biolabs – bovine antibodies with Ultralong CDR3s
- Keyence – microscopes and sensors
- Intercept Pharma – bile acid therapeutics
- Abbiotec – protein transfection reagent
- Cellular Research – high-resolution investigation of single cells
- Ocata therapeutics – regenerative ophthalmology
- Arbor Assays – enzyme activity kits
- Chromotek – single domain camel antibodies
- Cellecta – functional screening and drug target discovery
- Bionano Genomics – high-resolution single-molecule imaging to explore the genome
- Trilink – highly modified oligos
- Protea – bioanalytics
- Denovix – high quality Spectrophotometers and Fluorometers
- Aptagen – aptamer-beacon
- CLC Bio – sequence analysis software
- Abnova – innovation through integrated solutions
- Kite Pharma – engineered Autologous Cell Therapy
- Abraxis – immunochemistry products
- Transgenomic – genetic biomarker identification
- Epitogenesis – vaccine delivery technologies
- Boster – picoband antibodies
- Axerion Therapeutics – prion proteins
- Juno Therapeutics – next generation CAR technology
- DNAtrek – DNA barcode
- Bellicum – dendritic cell vaccines
- XenoTech – drug metabolism studies
- Wyatt Technology – macromolecular characterization
- Cellaria – tumor microenvironment
- Sangamo – zinc finger proteins therapeutics
- CMDBioscience – computational peptide discovery
- Organovo – 3D bioprinting
- Caribou Biosciences – engineering any genome
- Lucigen – isothermal nucleic acid amplification
- TissueGnostics – quantitative analysis of tissue images
- CRISPR Therapeutics – CRISPR-Cas9 genome-editing
- Epigentek – epigenetic products and services
- Schrodinger – advanced molecular simulations
- Applikon Biotechnology – advanced bioreactor systems
- ProFibrix – fibrinogen technology
- Taconic Biosciences – research model provider
- Second Genome – microbiome modulators
- Abiocode – vPair antibodies
- Motif Bio – antibiotics against multi-drug resistant bacteria
- Streck – cell stabilization
- Advanced Analytical – high-throughput nucleic acid analysis systems
- Biotek – microplate instrumentation and software
- Prior Scientific – microscope automation
- Gene Codes – bioinformatics solutions for DNA sequence analysis
- ProSci – affinity-purified polyclonal antibodies
- AMSBIO – tissue products
- Mimetas – organ-on-a-chip
- RayBiotech – antibody arrays
- IDEXX BioResearch – diagnostic services
- Horizon Technology – automated sample preparation systems
- Adaptimmune – engineered, increased affinity T cell receptors
- Sirion Biotech – viral vector platforms
- Novateinbio – endotoxin removal reagents
- Abgent – monoclonal antibody service
- Arthus Biosystems – S-adenosylmethionine and S-adenosylhomocysteine
- Immunodiagnostic systems – Vitamin D determination
- Syngene – gel imaging and analysis systems
- One World Lab – antibody validation
- Premier Biosoft – innovative software in life sciences
- Cancer Research Technology – cancer research innovations
- Biorbyt – custom peptide synthesis
- Zenith Epigenetics – bromodomain inhibitors
- Somalogic – proteomics tools
- TIB MolBiol – custom synthesis of oligonucleotides
- Vector Laboratories – labeling and detection solutions
- Horizon Discovery – genetically-defined cell lines
- CoolLED – LED illumination for fluorescence microscopy
- BioMarin – therapies for rare genetic diseases
- Valneva – innovative vaccines against infectious diseases
- ForteBio – analytical systems for biomolecular interactions
- CS Bio – peptide synthesizers
- Affymetrix – genomic analysis
- Integrated DNA Technologies – custom oligonucleotides
- BMG Labtech – microplate readers
- InvivoGen – innate immunology specialists
- Mirus Bio – the Transfection Experts
- Zymo Research – genome-wide epigenetic analyses
- Scienon – assay miniaturization
- Oxyrane – enzyme replacement therapies
- Oxford Gene Technology – genetics solutions
- Asterand – human tissue and biofluids
- Origene – your Gene company
- Kytogenics – chitosan derived technology
- Active Motif – epigenetic research
- Gentronix – genotoxicity assays
- AllCells – primary human cells
- GenCell – composite liquid cell
- Diagenode – epigenetics solutions
- Clontech – cloning tools
- GenoSensor – gene profiling and screening
- DiscoveRx – cell-based assays
- SwitchGear Genomics – genomic regulation
- Ribomed – biomarker detection
- SeqWright – next generation genomics
- Covaris – sample preparation by focused-ultrasonication
- CH3 BioSystems – methyl marks discovery
- Biogenex – cell and tissue staining
- ChemoMetec – high-speed cell counting
- eBioscience – immunology reagents
- ProSpec – bacterial-derived recombinant proteins
- NuGen – genomic sample preparation
- Apexigen – rabbit-derived humanized monoclonal antibodies
- Benitec – gene silencing by ddRNAi
- Protein Simple – powering protein research
- 3D Matrix – synthetic extracellular matrix
- Kapa Biosystems – enzyme solutions
- ActivX – in situ kinase profiling
- DNAStar – innovative and easy to use software for scientists
Biotech companies are listed according geographical points of view (continent / country). If you want to propose a Biotech company to be added to this list, please feel free to contact us !
To receive weekly notifications about the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers!
Lots of very interesting and promising Biotech Companies emerge everyday around the world. Looking for new partners? Biotech365 will present you lots of Biotech companies from all around the world! List of Biotech Companies : every day Biotech-365.com brings you information about the best Biotech Companies ! List Biotech Companies – List Biotech Company. You want to propose a Biotech Company to be presented on this website ? Please use our Contact page !
Biotech 365 is an independent website, sharing information and news about Biotech Companies and Biotechnology. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Biotech Companies USA – Biotech Company USA – List Biotech Companies USA – List of Biotech Companies from USA – List Biotech Company USA – Biotech Companies from USA – Biotech Company from USA
Biotech Companies Austria – Biotech Company Austria – List Biotech Companies Austria – List of Biotech Companies from Austria – List Biotech Company Austria – Biotech Companies from Austria – Biotech Company from Austria
List of Biotech Companies presented on this page : Biotech Companies USA – Biotech Company USA – List Biotech Companies USA . Biotech 365 brings you every day the more interesting information about Biotech Investors, Biotech Companies, Biopharma companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates !
Biotech Companies USA – Biotech Company USA – List Biotech Companies USA – List of Biotech Companies from USA – List Biotech Company USA – Biotech Companies from USA – Biotech Company from USA